The UK Government has confirmed that North Wales will be the location of a central new AI Growth Zone, expected to generate more than 3,400 jobs and unlock part of an estimated £100 billion in investment across the national programme.
Around 20,000 children and young people with type 1 diabetes in England now benefit from life-changing 'artificial pancreas' technology, recommended by NICE.
The European Commission has published a new evaluation of the Car Labelling Directive (Directive 1999/94/EC), revealing that while the policy has helped consumers make more informed vehicle choices, there is room for improvement to help meet the EU’s climate and digital goals.
Ofgem’s Strategic Innovation Fund (SIF) has awarded £12 million to support 15 new energy projects aimed at transforming Great Britain’s energy networks and accelerating the path to net zero emissions.
New results from a clinical trial reveal that a single dose of psilocybin can provide sustained reductions in depression and anxiety in individuals with cancer suffering from major depressive disorder.
This summer, a new generation of aerospace explorers will get an up-close look at careers in science, technology, engineering, and mathematics (STEM) through the 2025 Junior Test Pilot School.
A recent study from the University of Gothenburg has discovered that two existing medications can effectively treat alcohol use disorder, reducing both alcohol consumption and cravings.
In light of recent NHS England updates around accelerated digital maturity, the rollout of Scan for Safety, and trust-wide efforts to meet net zero targets, the need for agile, intelligent software has never been greater. That’s where SMS Technology steps in.
Mark Gannon, Director of Client Solution at Netcall, discusses the UK Government’s creation of unitary authorities as part of the abolition of the two-tier local government structures in England and the role of technology in this significant reorganisation.
Melissa Gong Mitchell, the Secretariat Lead at the AMR Industry Alliance, discusses the challenges hindering the development of urgently needed new antibiotics and the sustainable solutions needed to address these issues.
